Further studies on thyrotrophin releasing hormone analgesia
- PMID: 3121963
Further studies on thyrotrophin releasing hormone analgesia
Abstract
Thyrotrophin releasing hormone (TRH) administered subcutaneously produced dose dependent analgesia in acetic acid-induced writhing assay. There was no tolerance development when TRH was administered repeatedly either at 2-hr or 4-hr intervals. Furthermore, co-administration of TRH and morphine did not result in any potentiated effect. However, TRH pretreatment antagonized analgesic tolerance to morphine. On the contrary, with the dose employed, TRH failed to suppress abstinence signs in acute dependent animals. These results suggest that TRH may utilize mechanisms other than the opioid system to produce analgesia.
Similar articles
-
Role of calcium in prolactin analgesia.Arch Int Pharmacodyn Ther. 1986 Sep;283(1):56-60. Arch Int Pharmacodyn Ther. 1986. PMID: 3099670
-
[The modulating effect of the thyrotropin-releasing hormone on genetically induced mechanisms of morphine sensitivity].Zh Vyssh Nerv Deiat Im I P Pavlova. 1995 Nov-Dec;45(6):1174-81. Zh Vyssh Nerv Deiat Im I P Pavlova. 1995. PMID: 8585307 Russian.
-
Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.Brain Res. 2006 Jan 27;1070(1):35-44. doi: 10.1016/j.brainres.2005.11.054. Epub 2006 Jan 10. Brain Res. 2006. PMID: 16409995
-
Interactions of thyrotropin releasing hormone, its metabolites and analogues with endogenous and exogenous opiates.Gen Pharmacol. 1983;14(6):565-70. doi: 10.1016/0306-3623(83)90150-7. Gen Pharmacol. 1983. PMID: 6141121 Review.
-
Effect of neuropeptides on cognitive function.Exp Gerontol. 1997 Jul-Oct;32(4-5):451-69. doi: 10.1016/s0531-5565(96)00159-3. Exp Gerontol. 1997. PMID: 9315449 Review.